LifeSci Partners Podcast

Oct 03 2023 6
LifeSci Partners Podcast artwork

This podcast series, sponsored by LifeSci Partners, brings the listener right into the mindset, and motivations of some of the top players in the healthcare biotechnology industry.

RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry

Oct 03 2023 41 mins  
Tune into Episode #2 of the LifeSci Search podcast with Andy Cronin (President & Co-Founder) and Ayesha Price (Sr. Director, Executive Search) as they host Iris Grossman (Chief Therapeutics Officer, Eleven Therapeutics) and Shahram Ebadollahi (Operating Partner, ARCHIMED & Former Chief Data Officer, Novartis) on the topic of AI and ML tools in Drug R&D. We get insights

LifeSci Search Podcast: Episode #1

Mar 17 2023 37 mins  
Tune into Episode #1 of the LifeSci Search Podcast.

Regenerative Medicine from Humacyte: Off-the-Shelf, Human-Sourced Acellular Vessels for Traumatic Wound Repair

Feb 10 2023 36 mins  
In the clinical setting, the time it takes to address a serious problem can make the difference between life and death. To save as much time as possible, the necessary material – a vessel to do a coronary bypass, for example – needs to be readily available. However, due to the organic nature of that material, acquisition may take more time than you have, and the nature of the e

A Brief Chat with Erez Raphael, CEO of DarioHealth

Jan 06 2023 17 mins  
Tune into this 17-minute chat with Erez Raphael, CEO of DarioHealth (NASDAQ: DRIO).

Onconova – Developing Best-in-class Anti-cancer Agents with Multi-faceted MOAs

Jan 05 2023 30 mins  
CDK and RAS-targeting drugs already exist, but in the setting of oncology, if it’s not curative, it’s not enough. As a former practicing oncologist, Onconova’s CEO Dr. Steven Fruchtman knows this and has spent his career at the bench, and now the boardroom, working to improve and provide such drugs for cancer patients. His CDK 4/6 drug, Narazaciclib, a drug with a much-improv

A Brief Chat with Dror Bashan, President & CEO of Protalix Biotherapeutics, Inc.

Jan 04 2023 9 mins  
Tune into this 9-minute chat with Dror Bashan, President & CEO of Protalix Biotherapeutics, Inc. (NYSE: PLX).

A Brief Chat with Martin Welschof, CEO of BioInvent

Jan 03 2023 17 mins  
Tune into this 17-minute chat with Martin Welschof, CEO of BioInvent (STO: BINV).

A Brief Chat with Raphi Levy, CFO of Alpha Tau Medical Ltd.

Dec 29 2022 11 mins  
Tune into this 11-minute chat with Raphi Levy, CFO of Alpha Tau Medical Ltd. (NASDAQ: DRTS).

A Brief Chat with Amir London, CEO of Kamada Ltd.

Dec 28 2022 13 mins  
In this 13-minute chat, Amir London, CEO of Kamada Ltd. (NASDAQ: KMDA), discusses the growing commercial business of the company, including six FDA-approved products for rare and serious conditions, and its innovative development pipeline, targeting areas of significant unmet medical need.

A Brief Chat with Rob Etherington, President & CEO of Clene, Inc.

Dec 27 2022 14 mins  
In this 15-minute chat, Rob Etherington, President & CEO of Clene, Inc. (NASDAQ: CLNN) discusses the potential for nanosuspensions to improve cellular energy production and treat neurodegenerative diseases, along with Clene’s future directions.